Agomab Therapeutics NV (‘Agomab’) today announced positive interim results from 44 patients completing treatment in the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal ...

As these nature quotes prove, nature is full of infinite allure and ceaseless wonders. It beckons us to immerse ourselves in ...